✦ LIBER ✦

New developments in antibody therapy for acute myeloid leukemia

✍ Scribed by Marcie R Tomblyn; Martin S Tallman

Book ID: 114106625
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 149 KB
Volume: 30
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(03)00234-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody Therapy for Acute Myeloid Leuke

Antibody Therapy for Acute Myeloid Leukemia

✍ Deborah Mulford 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 118 KB

New targets for therapy in acute myeloid

New targets for therapy in acute myeloid leukemia

✍ Appelbaum, F R 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Acute myeloid leukemia developing during

Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities

✍ Attaphol Pawarode; Sheila N.J. Sait; Alain Nganga; Lionel J. Coignet; Maurice Ba 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 171 KB

The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been

Antibody Therapy for Acute Lymphoblastic

Antibody Therapy for Acute Lymphoblastic Leukemia

✍ Craig A. Portell; Anjali S. Advani 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 215 KB

Monoclonal antibody therapy directed aga

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells

✍ Majeti, R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 599 KB

New agents for induction and postremissi

New agents for induction and postremission therapy of acute myeloid leukemia

✍ Larson, RA 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB